Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

6082 ARTÍCULOS , VIENDO DEL 4051 AL 4065

PACAP in Parkinson's disease: A multifunctional neuropeptide at the crossroad of autophagy, inflammation, and metabolic repurposing

Hassan ME, Al-Kuraishy HM, Fawzy MN, Hussain NR, Al-Gareeb AI, Rashwan EK, Albuhadily AK, Batiha GE.

Neuropharmacology. 2026 Sep 15;296:111013. doi: 10.1016/j.neuropharm.2026.111013. Epub 2026 May 9.

When the Scale Drops: Pathways to Weight Loss in Parkinson's Disease and Future Directions

Gabriel ED, Eisinger RS, Lee JM, Hamimi S, Kim H, Howard SD, Halpern CH.

Mov Disord. 2026 Mar 4. doi: 10.1002/mds.70258. Online ahead of print.

Genetic and environmental risk factors of Parkinsonism

Kanovsky P, Mensikova K, Cupr P, Vodicka R, Kolarikova K, Strnadova T, Cook SEV, Sebelova-Konickova D, Klanova J, Colosimo C, Rosales R.

J Neural Transm (Vienna). 2026 Apr 6. doi: 10.1007/s00702-025-03058-z. Online ahead of print.

Subthalamic versus Posterior Subthalamic Stimulation for Optimal Tremor Control in Parkinson's Disease

Bellini G, Boccia VD, Ceravolo R, Mogilner A, Pourfar MH.

Stereotact Funct Neurosurg. 2026;104(3):213-224. doi: 10.1159/000549916. Epub 2025 Dec 18.

Differential effects of focused ultrasound neuromodulation in Parkinson's disease mice versus healthy mice

Yang L, Xu K, Zhang D, Stark A, Yue Y, Kravitz A, Yang Y, Chen H.

J Neural Eng. 2026 Feb 25;23(1):016031. doi: 10.1088/1741-2552/ae4383.

FGF-FGFR Signaling in Parkinson's Disease: Mechanistic Links to Ferroptosis and Neuroprotection

Wang H, Wen X, Yan M, Li R, Mao D, Tian X.

Brain Sci. 2026 Jan 29;16(2):151. doi: 10.3390/brainsci16020151.

Immediate Effects of a Jewett Brace on Posture and Dynamic Balance in Parkinson's Disease-Associated Camptocormia: A Case Report

Nakamoto C, Bando K, Mukai Y, Takahashi Y, Seki K, Hara T.

Cureus. 2026 Jan 30;18(1):e102612. doi: 10.7759/cureus.102612. eCollection 2026 Jan.

Spermidine in the aging brain: mechanisms, preclinical evidence, and clinical perspectives

Pandolfi S, Björklund G, Ghezzi C, Paone FM, Chirumbolo S.

Mol Biol Rep. 2026 Apr 21;53(1):643. doi: 10.1007/s11033-026-11827-6.

[Research progress on the molecular genetic mechanism of Parkinson's disease]

Quan W.

Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2026 Feb 10;43(2):151-157. doi: 10.3760/cma.j.cn511374-20251021-00617.

Unveiling the Role of Sex Hormones and Reproductive Life Factors in Parkinson's Disease

Bovenzi R, Simonetta C, Mancini M, Buttarazzi V, Stefani A, Schirinzi T.

Mov Disord Clin Pract. 2026 Feb 11. doi: 10.1002/mdc3.70543. Online ahead of print.

Organelle-Targeted Nanotherapeutics for Parkinson's Disease: From Pathogenesis to Preclinical Strategies and Translational Challenges

Liu M, Peng Q, Zhai H, Wu Y, Ma Z, Tang Z, Ouyang H, Chang A, Cao X, Xu Y, Xia Y.

Int J Nanomedicine. 2026 May 13;21:607870. doi: 10.2147/IJN.S607870. eCollection 2026.

The vicious cycle: unraveling the interplay between α-synuclein, mitochondrial dysfunction, and neuroinflammation in Parkinson's disease

Liang YL, Yang FG, Tang Q.

J Neurol. 2026 May 30;273(6):350. doi: 10.1007/s00415-026-13900-3.

Exercise as Chronotherapy: Regulating Circadian Rhythms to Alleviate Symptoms in Parkinson's Disease

Li J, Liu T, Wei J.

ACS Chem Neurosci. 2026 Mar 18;17(6):1064-1077. doi: 10.1021/acschemneuro.5c00844. Epub 2026 Mar 1.

Nanotherapeutic Interventions for Parkinson's Disease: Modulating Pathogenic Mechanisms and Overcoming Therapeutic Obstacles

Yin X, Wang C, Lin W, Huang S, Chen T.

Int J Nanomedicine. 2026 Feb 7;21:570452. doi: 10.2147/IJN.S570452. eCollection 2026.

VGLUT2 in Parkinson's disease: an emerging therapeutic target

Freyberg Z, Torregrossa MM, Rocha EM.

Expert Opin Ther Targets. 2026 Feb;30(2):103-107. doi: 10.1080/14728222.2026.2619754. Epub 2026 Jan 20.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias